👨⚕️ AI-Driven Virtual Human for GP Obesity Training
This document presents a pilot feasibility study published in “Obesity Science & Practice” that investigates the effectiveness of an AI-driven Virtual Human (VH) intervention designed to enhance General Practitioner (GP) obesity education and communication skills. The research highlights the growing global obesity rates and the need for GPs to possess effective weight management strategies and communication abilities. The study aimed to address […]
Why do some people have better weight loss results with Ozempic or Wegovy?
Post Content
From Delhi to Dubai: The global food trends to watch
A dispatch from the Summer Fancy Food Show featuring Korean carbonara and treats designed to fit your GLP-1 diet.
Bull of the Day: Hims & Hers Health (HIMS)
Hims & Hers Health (HIMS) is quickly becoming one of the most compelling stories in the market as an emerging powerhouse in the direct-to-consumer healthcare space. The stock has posted outsized gains over the last two years, driven by explosive growth and rising investor enthusiasm, even as it navigates controversy over its efforts to compound […]
Nordic Cold Chain launches cold chain packaging for GLP-1 drugs
Post Content
Quantitative analysis of the efficacy characteristics and influencing factors of weight loss drugs in children and adolescents
Abstract Background This study fills a gap in the current guidelines for paediatric obesity treatment by providing quantitative data and comparing the effectiveness of weight loss drugs in children and adolescents with that in adults. Researchers developed a pharmacodynamic model to evaluate the efficacy and influential factors of various weight loss drugs. Method A systematic […]
The Genetic Blueprint of Obesity: From Pathogenesis to Novel Therapies
ABSTRACT Obesity is a chronic metabolic disease characterized by disturbances in energy homeostasis, leading to excessive fat accumulation. The pathogenesis of the disease is shaped by a complex interplay of genetic, epigenetic, biological, psychological, and environmental factors. These contributors affect regulatory mechanisms in the hypothalamus, hormonal signaling, and the gut-brain axis, all of which control […]
China has 60 drugs under trial to rival Ozempic in US$150 billion weight-loss market
Illustration by Henry Wong. When Hong Kong office worker W.K. Chan began putting on weight as a teenager, her doctor said it was due to hormonal imbalances that slowed her metabolism. She reached a peak weight of 100kg about a year ago, but has since lost 25kg. The secret to losing a quarter of her […]
This week in 5 numbers: Nearly a quarter of companies offer GLP-1 drug coverage for weight management
Post Content
Thoughts on $HIMS? Crash and burn, or rise like a phoenix?
With HIMS earnings call on the way (August 4th) I’ve been deciding which strategy to take. I was previously confident in my decision to buy calls leading up to earnings considering their previous reports, but with all the bad PR with NOVO, the fact they literally are breaking the law, and no longer have a […]